Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study
ConclusionTCZ can treat active moderate-to-severe TED, showing high drug compliance and reasonable response to inflammation and extraocular motility abnormality.
Source: International Ophthalmology - Category: Opthalmology Source Type: research
More News: Actemra | Corticosteroid Therapy | CT Scan | Dermatitis | Dermatology | Headache | Herpes | Migraine | Opthalmology | Study | Thyroid